Literature DB >> 7609028

Vaccinia virus A17L gene product is essential for an early step in virion morphogenesis.

D Rodríguez1, M Esteban, J R Rodríguez.   

Abstract

Vaccinia virus (VV) A17L gene encodes a 23-kDa protein that is proteolytically cleaved to generate a 21-kDa product that is incorporated into the viral particles. We have previously shown that the 21-kDa protein forms a stable complex with the VV 14-kDa envelope protein and suggested that the 21-kDa protein may serve to anchor the 14-kDa protein to the envelope of the virion (D. Rodríguez, J. R. Rodríguez, and M. Esteban, J. Virol. 67:3435-3440, 1993). To study the role of the 21-kDa protein in virion assembly, in this investigation we generated a VV recombinant, VVindA17L, that contains an inducible A17L gene regulated by the E. coli repressor/operator system. In the absence of the inducer, shutoff of the A17L gene was complete, and this shutoff correlated with a reduction in virus yields of about 3 log units. Although early and late viral polypeptides are normally synthesized in the absence of the A17L gene product, proteolytic processing of the major p4a and p4b core proteins was clearly impaired under these conditions. Electron microscopy examination of cells infected in the absence of isopropylthiogalactopyranoside (IPTG) revealed that virion morphogenesis was completely arrested at a very early stage, even prior to the formation of crescent-shaped membranes, which are the first distinguishable viral structures. Only electron-dense structures similar to rifampin bodies, but devoid of membranes, could be observed in the cytoplasm of cells infected with VVindA17L under nonpermissive conditions. Considering the most recent assembly model presented by Sodeik et al. (B. Sodeik, R. W. Doms, M. Ericsson, G. Hiller, C. E. Machamer, W. van't Hof, G. van Meer, B. Moss, and G. Griffiths, J. Cell Biol. 121:521-541, 1993), we propose that this protein is targeted to the intermediate compartment and is involved in the recruitment of these membranes to the viral factories, where it forms the characteristic crescent structures that subsequently result in the formation of virions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7609028      PMCID: PMC189265          DOI: 10.1128/JVI.69.8.4640-4648.1995

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  A constitutively expressed vaccinia gene encodes a 42-kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope.

Authors:  M Engelstad; S T Howard; G L Smith
Journal:  Virology       Date:  1992-06       Impact factor: 3.616

2.  Vaccinia virus morphogenesis is blocked by a temperature-sensitive mutation in the I7 gene that encodes a virion component.

Authors:  E M Kane; S Shuman
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

3.  Insertional mutagenesis in the extreme thermophilic eubacteria Thermus thermophilus HB8.

Authors:  I Lasa; J R Castón; L A Fernández-Herrero; M A de Pedro; J Berenguer
Journal:  Mol Microbiol       Date:  1992-06       Impact factor: 3.501

4.  The vaccinia virus 14-kilodalton fusion protein forms a stable complex with the processed protein encoded by the vaccinia virus A17L gene.

Authors:  D Rodriguez; J R Rodriguez; M Esteban
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

5.  Dissociation of progeny vaccinia virus from the cell membrane is regulated by a viral envelope glycoprotein: effect of a point mutation in the lectin homology domain of the A34R gene.

Authors:  R Blasco; J R Sisler; B Moss
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

6.  Identification and characterization of an extracellular envelope glycoprotein affecting vaccinia virus egress.

Authors:  S A Duncan; G L Smith
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

7.  Characterization of a vaccinia virus-encoded 42-kilodalton class I membrane glycoprotein component of the extracellular virus envelope.

Authors:  S N Isaacs; E J Wolffe; L G Payne; B Moss
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

8.  The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence.

Authors:  M Engelstad; G L Smith
Journal:  Virology       Date:  1993-06       Impact factor: 3.616

9.  The development of vaccinia virus in Earle's L strain cells as examined by electron microscopy.

Authors:  S DALES; L SIMINOVITCH
Journal:  J Biophys Biochem Cytol       Date:  1961-08

10.  Assembly of vaccinia virus: role of the intermediate compartment between the endoplasmic reticulum and the Golgi stacks.

Authors:  B Sodeik; R W Doms; M Ericsson; G Hiller; C E Machamer; W van 't Hof; G van Meer; B Moss; G Griffiths
Journal:  J Cell Biol       Date:  1993-05       Impact factor: 10.539

View more
  58 in total

1.  Clustered charge-to-alanine mutagenesis of the vaccinia virus H5 gene: isolation of a dominant, temperature-sensitive mutant with a profound defect in morphogenesis.

Authors:  J DeMasi; P Traktman
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

2.  Regulation of vaccinia virus morphogenesis: phosphorylation of the A14L and A17L membrane proteins and C-terminal truncation of the A17L protein are dependent on the F10L kinase.

Authors:  T Betakova; E J Wolffe; B Moss
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

3.  Entry of the two infectious forms of vaccinia virus at the plasma membane is signaling-dependent for the IMV but not the EEV.

Authors:  J K Locker; A Kuehn; S Schleich; G Rutter; H Hohenberg; R Wepf; G Griffiths
Journal:  Mol Biol Cell       Date:  2000-07       Impact factor: 4.138

4.  Effects of deletion or stringent repression of the H3L envelope gene on vaccinia virus replication.

Authors:  F G da Fonseca; E J Wolffe; A Weisberg; B Moss
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

5.  The vaccinia virus A9L gene encodes a membrane protein required for an early step in virion morphogenesis.

Authors:  W W Yeh; B Moss; E J Wolffe
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

6.  Selective induction of host genes by MVA-B, a candidate vaccine against HIV/AIDS.

Authors:  Susana Guerra; José Manuel González; Núria Climent; Hugh Reyburn; Luis A López-Fernández; José L Nájera; Carmen E Gómez; Felipe García; José M Gatell; Teresa Gallart; Mariano Esteban
Journal:  J Virol       Date:  2010-06-09       Impact factor: 5.103

7.  Evidence for an essential catalytic role of the F10 protein kinase in vaccinia virus morphogenesis.

Authors:  Patricia Szajner; Andrea S Weisberg; Bernard Moss
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

8.  Investigation of structural and functional motifs within the vaccinia virus A14 phosphoprotein, an essential component of the virion membrane.

Authors:  Jason Mercer; Paula Traktman
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

9.  African swine fever virus protein p17 is essential for the progression of viral membrane precursors toward icosahedral intermediates.

Authors:  Cristina Suárez; Javier Gutiérrez-Berzal; Germán Andrés; María L Salas; Javier M Rodríguez
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

10.  Differences in virus-induced cell morphology and in virus maturation between MVA and other strains (WR, Ankara, and NYCBH) of vaccinia virus in infected human cells.

Authors:  Juan Carlos Gallego-Gómez; Cristina Risco; Dolores Rodríguez; Pilar Cabezas; Susana Guerra; José L Carrascosa; Mariano Esteban
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.